Radioactive seeds zapped tumors from inside – early trial shows promise

NCT ID NCT03737734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a device called DaRT that delivers alpha radiation directly into tumors. It is for people with skin cancer, mouth tumors, or superficial soft tissue sarcoma who have not responded to other treatments or cannot have standard therapy. The goal is to see if the device can shrink tumors and how safe it is. Thirty participants are enrolled, and the study is active but no longer recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Diffusing Alpha Radiation Emitters Therapy (DaRT) device
What this could lead to
If it works, this could offer a new treatment option for people with certain skin, mouth, or soft tissue cancers who cannot have or refuse standard treatments.
What could go wrong
This is an early study with only 30 people, so results may not apply to everyone. The treatment involves inserting radioactive seeds into the tumor, which carries risks like infection or radiation side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUCOSAL NEOPLASM OF ORAL CAVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Davidof Cancer Institution at the Rabin Medical Center Israel

    Petah Tikva, 49100, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.